Why Infection Control Is Trending in 2025
In the wake of post-pandemic healthcare transformation, infection control has emerged as a critical pillar of hospital safety, pharmaceutical production, and patient care. By 2025, growing concerns over healthcare-associated infections (HAIs), stricter sterilization standards, and an expanding number of surgical procedures are pushing healthcare systems worldwide to invest in advanced infection prevention technologies.
The infection control market — encompassing sterilization equipment, disinfection solutions, and endoscope reprocessing systems — is evolving rapidly through digitalization, automation, and sustainability-driven innovation. As of 2025, the market stands at USD 14.99 billion, projected to reach USD 20.58 billion by 2030, at a CAGR of 6.6%.
Latest Developments (2024–2025): Strategic Growth and Innovation
Recent years have seen accelerated product innovation, acquisitions, and collaborations among major players seeking to strengthen their infection control portfolios:
-
August 2023: STERIS plc (US/Ireland) completed a USD 540 million acquisition of sterilization container and surgical instrument assets from Becton, Dickinson and Company. This deal expanded STERIS’s sterile processing portfolio and added approximately USD 170 million in annual revenue.
-
November 2022: Reckitt Benckiser (UK) launched a co-branded professional hygiene product line with Essity, integrating Dettol and Sagrotan into Tork’s institutional distribution network across the UK, Germany, Ireland, and Austria — expanding professional-use disinfection solutions for hospitals and clinics.
-
Paul Hartmann AG (Germany) expanded its Mission: Infection Prevention initiative, in collaboration with the WHO’s Patient Safety Day, focusing on reducing HAIs through tailored disinfection plans, digital hygiene monitoring, and training under its BODE Science Center.
These developments underscore how strategic partnerships and AI-enabled monitoring tools are redefining infection control standards in both healthcare and industrial environments.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=11051524
Market Overview & Key Insights
The global infection control market is projected to grow from USD 14.99 billion in 2025 to USD 20.58 billion by 2030, at a CAGR of 6.6%.
Market Drivers:
-
Increasing healthcare-associated infections (HAIs) and surgical procedures.
-
Advancements in sterilization and reprocessing technologies.
-
Rising focus on food industry hygiene and biopharma manufacturing.
-
Growing outsourcing of infection control services for cost efficiency.
Restraints:
-
Safety concerns over reprocessed instruments.
-
Side effects linked to chemical disinfectants.
-
High costs associated with endoscopy reprocessing systems.
Top Companies (2024–2025):
-
STERIS plc (US) – Market leader in sterilization and contract processing services.
-
Reckitt Benckiser (UK) – Pioneer in consumer and professional disinfection products.
-
Paul Hartmann AG (Germany) – Leader in barrier solutions and healthcare hygiene.
-
Getinge AB (Sweden), Ecolab, Inc. (US), Solventum Corporation (US), Olympus Corporation (Japan), and B. Braun Group (Germany) also maintain strong market presence.
Together, these companies drive innovation, compliance, and operational excellence across the infection control ecosystem.
Regional Analysis
North America
The region dominates the global infection control market, driven by high healthcare spending, strong regulatory frameworks (FDA, CDC), and robust adoption of sterilization and disinfection protocols in hospitals and laboratories.
Europe
Europe’s infection control market is highly competitive and innovation-driven. Key players like STERIS, Reckitt Benckiser, and Paul Hartmann AG lead through technological integration, hygiene awareness programs, and strong institutional partnerships.
-
STERIS maintains leadership through sterilization systems and contract sterilization services.
-
Reckitt Benckiser has expanded professional hygiene solutions across Europe.
-
Paul Hartmann AG has scaled its production of Sterillium and digital infection prevention tools.
Asia-Pacific
APAC is witnessing rapid growth due to expanding healthcare infrastructure, local manufacturing, and public health initiatives. Governments in China, India, and Japan are investing in infection control for hospitals, pharmaceutical facilities, and medical device manufacturing.
Latin America
Driven by rising healthcare awareness and public–private partnerships, Latin American countries are strengthening infection prevention protocols in hospitals and ambulatory centers.
Middle East & Africa
MEA is an emerging market supported by hospital modernization projects and regional investments in healthcare infrastructure, particularly in the UAE, Saudi Arabia, and South Africa.
Technology Drivers & Opportunities
Modern infection control technologies are leveraging automation, IoT, and data analytics to optimize sterilization efficiency and compliance:
-
AI-powered monitoring for hospital hygiene and sterilization tracking.
-
Smart disinfection robots for surface cleaning in clinical environments.
-
Sustainable sterilization using eco-friendly agents and energy-efficient equipment.
-
Cloud-based data systems for reprocessing traceability and audit readiness.
Opportunities:
-
Expansion in hospital sterilization outsourcing services.
-
Digital infection tracking integrated with hospital information systems.
-
Growth of eco-conscious disinfectants and low-toxicity sterilization solutions.
-
Collaboration between medtech and biotech companies for cross-industry innovation.
Challenges & Barriers
-
Regulatory compliance and the need for continuous validation of sterilization processes.
-
Safety and chemical exposure risks for healthcare personnel.
-
High capital expenditure for advanced reprocessing equipment.
-
Supply chain disruptions affecting availability of sterilants and consumables.
Future Outlook (2025–2030)
Between 2025 and 2030, the infection control market will undergo a significant digital transformation. Hospitals and pharmaceutical manufacturers will adopt automated sterilization workflows, AI-based disinfection validation, and green chemistry disinfectants to meet regulatory and sustainability goals.
Europe and North America will remain technology leaders, while Asia-Pacific will emerge as the fastest-growing region due to local manufacturing and government-funded hospital upgrades. Strategic acquisitions and cross-sector collaborations are expected to shape the competitive landscape, enabling companies to offer end-to-end infection prevention ecosystems.
Lead Generation & Business Opportunities
For medical device firms, disinfection technology companies, and healthcare investors, the infection control market presents robust opportunities to:
-
Partner with hospitals for end-to-end sterilization service models.
-
Develop AI-integrated monitoring and reporting platforms.
-
Expand into eco-friendly disinfectant manufacturing.
-
Collaborate on public health projects and industrial hygiene programs.
With infection prevention becoming central to patient safety and operational sustainability, the sector offers strong ROI potential for innovation-led partnerships and next-generation technology providers.
Key Takeaways
-
The infection control market is projected to reach USD 20.58 billion by 2030, at a CAGR of 6.6%.
-
Growth is driven by HAIs, surgical expansion, and digital reprocessing technologies.
-
STERIS, Reckitt Benckiser, and Paul Hartmann AG lead the European market.
-
AI, automation, and eco-friendly sterilization are transforming infection prevention.
-
Emerging markets in Asia-Pacific and MEA present strong expansion opportunities.